As a longtime partner of MedTech Innovator – the world’s largest accelerator for medical technology, digital health, and diagnostic companies – Johnson & Johnson is pleased to share that the 2023 application cycle for MedTech Innovator and BioTools Innovator is now open. Applications are due January 31, 2023.

MedTech Innovator is the largest accelerator of medical devices in the world and the medical technology industry’s global showcase and accelerator for innovative medical device, digital health, and diagnostic companies. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. Accelerator companies compete for up to $500,000 in non-dilutive funding.

BioTools Innovator (powered by MedTech Innovator) is the first-ever accelerator for life science tools and diagnostics. After nearly a decade in the MedTech industry, MedTech Innovator launched BioTools Innovator in 2021 with a mission of improving human health by supporting innovators developing a broad spectrum of biotechnology products, platforms, and services. Accelerator companies compete for up to $300,000 in non-dilutive funding.

What They’re Looking For:
MedTech Innovator is looking for outstanding early-to-mid-stage medical device, digital health, and diagnostics companies, while BioTools Innovator is seeking outstanding early-to-mid-stage life science research tools and molecular-based diagnostic companies.

Benefits:
Companies selected for MedTech Innovator and BioTools Innovator programs will receive:

• High-profile visibility
• Access to investors, stakeholders, and decision-makers
• A network of mentors and peers
• Participation in a customized educational curriculum

Companies selected for the 2023 cohort will also compete for $1 million in cash prizes. There is no application fee, and MedTech Innovator and BioTools Innovator do not charge or take equity for participation.